Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki et al. Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan. // Therapeutic Apheresis and Dialysis. – 2026. – DOI: 10.1002/1744-9987.70182. – URL: https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70182?af=R
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, & Tomohiko Asamura (2026). Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70182
Tadao Akizawa, et al. “Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan.” Therapeutic Apheresis and Dialysis, 2026. doi:10.1002/1744-9987.70182.
@article{Akizawa2026,
title = {Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan},
author = {Akizawa, Tadao and Kanaya, Kyomi and Aizawa, Kiyomi and Onoki, Masanori and Ozeki, Hirofumi and Suzuki, Kazuko and Hayashi, Ai and Asamura, Tomohiko},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70182},
url = {https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70182?af=R}
}